Publication: Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis
No Thumbnail Available
Date
2010-10
Authors
Gürel, Selim
Authors
Marcellin, Patric
Buti, Maria
Krastev, Zahary
Di Bisceglie, Adrian M.
Odin, Joseph A.
Dusheiko, Geoffrey
Heathcote, E. Jenny
E. Jenny, Katyna
Coombs, Derek
Mondou, Elsa
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Bu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
Keywords
Gastroenterology & hepatology
Citation
Marcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.